How to bid in this country: portals, deadlines, thresholds →
Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredient/active ingredient combinations with the possibility of conclusion at any time within the scope of the so-called Open House procedure
Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens — original title
Your path to submission
- Deadline: 5 December 2027 at 23:58 — 400 days left.
- You submit on Vergabemarktplatz (cosinex) — not here and not by e-mail. ↗ Free bidder account on the cosinex platform required (created instantly); offers go through the bidding tool, usually plain text form suffices — no qualified signature. Sort out account and signature first — not on submission day.
- Offer and evidence in: German.
- Collect your evidence — use the eligibility analysis on this page: it lists the requirements and, for known certificates, how to get them.
What the buyer is looking for
The subject of this publication is the conclusion of agreements pursuant to Section 130a(8) SGB V on various active substances/active substance combinations within the framework of a so-called Open House procedure. Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement pursuant to § 130a(8) SGB V on the active substance(s)/combined active substance(s). Interested pharmaceutical companies can, after registration, order documents (participation documents and contract) at: https://www.dtvp.de/Satellite/notice/CXP4Y6MMRJK download. The e-mail address specified in the Client section for the purpose of unrestricted and complete free access to the order documents does not exist. Information can only be obtained…
Show full description
… via your registration on the "DTVP" allocation platform under the "Communication" tab. Information and answers about other bodies are not binding. A prerequisite for the conclusion of a contract is that the interested pharmaceutical company submits the required procedural documents in full and signed. Any pharmaceutical company that meets the eligibility requirements and documents this by signing the declarations and discount agreement can join the discount agreement. NEW: The possibility of a qualified electronic signature is now also offered. For more information, please refer to the "Procedural Information" form. There is no exclusivity. Accession or conclusion of the contract may take place at any time and under the same conditions. Individual contract negotiations are not carried out. The start of the contract can only be one month at a time. The earliest contract start date is 01.02.2026. On this basis, the maximum duration of the contract is 24 months. The contract ends no later than 31.01.2028, regardless of the date of conclusion of the contract. The deadline for the submission of tenders is always the 5th of the previous month. (Example: Contract start 01.02.2026; Deadline for submission of tenders: 05.01.2026). Should AOK Nordost award an exclusive contract for the active substance(s)/combination of active substances within the framework of an open procedure during the contract period, the contractual provisions concluded within the framework of this publication shall apply. This publication does not constitute the award of a public contract within the meaning of the Public Procurement Coordination Directive 2014/24/EU of the European Parliament and of the Council or of public procurement law. Publication in the Supplement to the Official Journal of the European Union shall be carried out in order to ensure the widest possible degree of transparency with regard to the intended conclusion of contracts. In the absence of a publication form, this form of contract notice shall be used. The resulting conceptual requirements, such as the procedural designation of open proceedings, are solely due to the use of this notice form and the publication platform. A further meaning, in particular a submission to public procurement regulations, insofar as they are not obligated for legal reasons, is not associated with this. An announcement of the awarded contracts takes place exclusively under the following link: https://www.aok.de/gp/medicinal products/discount contract background.
Contract
Type of service
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (20 awards, most recently August 2021) — by that rhythm the next award was due around October 2021. The last award went to Bayer Vital GmbH.n = 20
- 24% of this buyer's awards went to companies that had already won here before (59 awards since 2018, spread over 45 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 59 awards since 2018
- The median procedure drew 2 bids (59 procedures with a bid count); 47% ended with a single bidder. Sector: median 2 bids.n = 59
- Across 24 procedures with structured selection criteria, this buyer most often required: Staff qualifications (23 of 24), Trade register enrolment (22 of 24), Security of supply required (1 of 24), Professional liability insurance (1 of 24).n = 24
- Not one of the 59 awards with a known winner country has gone to a foreign company so far. Sector average: 1%.n = 59
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 25/10/2026.
What you must prove — eligibility criteria
Tender documents — direct download
Who has won at this buyer so far
Across all contract types of this buyer — not just this sector. A city buys software and fire engines through the same purchasing office.
| Company | Awards | Period |
|---|---|---|
| Hexal AG · Holzkirchen | 21 | 2013–2016 |
| ratiopharm GmbH | 17 | 2013–2016 |
| Aliud Pharma GmbH · Laichingen | 15 | 2013–2016 |
| STADAPHARM GmbH · Bad Vilbel | 13 | 2014–2016 |
| TAD Pharma GmbH · Cuxhaven | 12 | 2013–2016 |
How often this buyer tenders this kind of work
Contracting authority contact
Tactics
When this buyer has awarded in this sector, usually 19 or more bids came in. Many compete here — price and references decide. (Based on 387 completed awards — not a statement about this procedure.)
This procedure allows 724 days between publication and deadline — typical in this country is 32 (median of 20,071 procedures). Much more generous than usual — time for a thorough bid rather than a quick one.
Foreign bidders
In Germany · Medical equipment & pharma, 270 contracts went to foreign companies over the last 3 years (of 22,355 recorded awards) — mostly from Austria, Netherlands, France.
Submission language: German.
How to bid
Don't miss the next one
Friedrich finds tenders like this for you — every morning at 7:30, each one checked by Claude (Anthropic) for fit, and he learns from your feedback what your company really does.
Register now